CS logo
small CS logo
Fourth Hospital of Hebei Medical University Breast cancer department

Shijiazhuang, Hebei, China

About Fourth Hospital of Hebei Medical University Breast cancer department


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
BeyondSpring Pharmaceuticals Inc.
2
Total Rows: 1

Clinical Trials at Fourth Hospital of Hebei Medical University Breast cancer department


During the past decade, Fourth Hospital of Hebei Medical University Breast cancer department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110011000000Started TrialsCompleted Trails20172018201900.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
2019-10-23
2025-09-25
Active, not recruiting
221
Plinabulin iv Solution in Prevention of TAC Induced Neutropenia
2017-11-27
2019-01-03
Completed
115

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsBeyondSpringPharmaceuticals Inc.: 2BeyondSpringPharmaceuticals Inc.: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Fourth Hospital of Hebei Medical University Breast cancer department


According to Clinical.Site data, the most researched conditions in "Fourth Hospital of Hebei Medical University Breast cancer department" are "Chemotherapy-induced Neutropenia" (2 trials). Many other conditions were trialed in "Fourth Hospital of Hebei Medical University Breast cancer department" in a lesser frequency.

Clinical Trials Intervention Types at Fourth Hospital of Hebei Medical University Breast cancer department


Most popular intervention types in "Fourth Hospital of Hebei Medical University Breast cancer department" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel, doxorubicin, and cyclophosphamide (TAC)" (2 trials), "Pegfilgrastim" (2 trials), "Plinabulin" (2 trials) and "D5W Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Fourth Hospital of Hebei Medical University Breast cancer department


The vast majority of trials in "Fourth Hospital of Hebei Medical University Breast cancer department" are 2 trials for "Female" genders.

Clinical Trials Status at Fourth Hospital of Hebei Medical University Breast cancer department


Currently, there are NaN active trials in "Fourth Hospital of Hebei Medical University Breast cancer department". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fourth Hospital of Hebei Medical University Breast cancer department, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fourth Hospital of Hebei Medical University Breast cancer department, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 1Active, not recruiting: 1Completed: 1Completed: 1